Safety and efficacy of pitolisant on cataplexy in patients with narcolepsy: a randomised, double-blind, placebo-controlled trial
Zoltán Szakács(Buda Health Center), Arben N Tavarari, И. Е. Повереннова(Samara Regional Clinical Hospital named after V.D. Seredavina), Karel Šonka(Charles University), Ivan Staykov, W. Jernajczyk, Dorota Wołyńczyk-Gmaj, М Г Полуэктов, Isabelle Lecomte(Bioprojet (France)), V. I. Mikhaylov(St.Petersburg V.M.Bekhterev Psychoneurological Research Institute), Sergei Krylov, А. Л. Калинкин(Lomonosov Moscow State University), Yves Dauvilliers(Inserm), Murat Aksu(Erciyes University), Slavko Janković(Centar za Promociju Nauke), Jean‐Charles Schwartz(Inserm), Hikmet Yılmaz(Manisa Celal Bayar University), Philippe Lehert(The University of Melbourne), Jeanne‐Marie Lecomte(Bioprojet (France)), E Z Yakupov
Cited by 334
Related Papers
National Sleep Foundation's sleep quality recommendations: first report
|Sleep Health|2016|1.3k
Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study
|Brain|2019|1.1k
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
|Gastroenterology|2016|1k
Narcolepsy with cataplexy
|The Lancet|2007|716